<qa>  What was the kinase inhibitors Encorafenib?Trial for patients with refractory multiple myeloma after failure of at least two treatment regimens and with BRAFV600EK Mutation to evaluate the efficacy of the kinase inhibitors Encorafenib LGX818 in combination with Binimetinib MEK162. 